We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Stresses Risk Assessments In Q&A on cGMP, Process Controls
FDA Stresses Risk Assessments In Q&A on cGMP, Process Controls
January 3, 2012
Drugmakers befuddled by manufacturing failures, such as product contamination by microorganisms, are urged to perform risk assessments and take preventive action, the FDA says.